Michigan Head Pain & Neurological Institute
Ann Arbor, Michigan 48104
We've found
7 trials
at this facility
Migraine Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Updated: 1/25/2012
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Status: Enrolling
Updated: 1/25/2012
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
Updated: 5/4/2016
A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 5/4/2016
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Updated: 12/9/2014
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Status: Enrolling,
Phase
III
Updated: 12/9/2014
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials